#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Crohn's disease Emphysema Li-Fraumeni syndrome Turner's syndrome Richter's syndrome Rhabdomyosarcoma recurrent VEXAS syndrome Neutropenia Canavan disease Pancreatic carcinoma metastatic Amyotrophic lateral sclerosis Neuroblastoma recurrent Bulbospinal muscular atrophy congenital Langerhans cell sarcoma Hypergammaglobulinaemia benign monoclonal More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome – Life with Disease Stevens-Johnson syndrome – Diagnostics Amyotrophic lateral sclerosis – Trials in Disease Cerebral arteriovenous malformation haemorrhagic Ocular melanoma Ornithine transcarbamoylase deficiency – Trials in Disease Sarcoma – Diagnostics Netherton’s syndrome – Diagnostics Familial amyotrophic lateral sclerosis – Diagnostics Mucopolysaccharidosis II More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clozapine Denosumab Nesolicaftor Sodium Chloride Solution 0.9% M1P Dipotassium Salt Ganirelix ATTR-01 Vemurafenib AZD0120 SC0062 Corticosteroids, Plain Fasudil Hydrochloride Tinzaparin GSKVX000000034795 Bt-001 MZE829 Amiloride Hydrochloride Chloride Ion Ixazomib Polatuzumab Vedotin More therapies…

    Learn about Your Condition

    Ocular melanoma Vulvar dysplasia Hand dermatitis Lower limb fracture Chronic disease Oesophagectomy Poor quality sleep Hepatic adenoma Tendon injury Staphylococcal infection Demyelination Axial spondyloarthritis Small cell carcinoma Oesophageal achalasia Cortisol abnormal More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Axon Clinical s.r.o.

Axon Clinical s.r.o.

Ostrovskeho 253/3, Smichov, Prague, 150 00, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Long-term Safety of JNJ-81201887 for Patients with Geographic Atrophy Due to Age-related Macular Degeneration

    Recruiting

    2 1 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Adeno-Associated Virus Serotype 2 Encoding Soluble Cd59
    • Triamcinolone Acetonide
    • Prednisone
    Belgium Czechia Denmark Germany Hungary Italy +5

  • Study on Tinlarebant for Treating Geographic Atrophy in Patients

    Recruiting

    3 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Tinlarebant
    Czechia France

  • Study on the Effects of MORF-057 for Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    2 1
    Investigated Drugs:
    • Morf-057
    Austria Bulgaria Croatia Czechia Estonia France +8

  • Study on the Long-Term Effects and Safety of Mirikizumab for Patients with Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Drugs:
    • Mirikizumab
    Austria Belgium Croatia Czechia France Germany +8

  • Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn’s Disease

    Recruiting

    2 1
    Investigated Drugs:
    • Zasocitinib
    Belgium Bulgaria Czechia Denmark France Germany +8

  • A Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    Investigated Drugs:
    • Fluorescein Sodium
    • Aflibercept
    Austria Croatia Czechia Denmark France Hungary +4

  • Study of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks

    Recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Austria Czechia Denmark France Germany Italy +3

  • A study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn’s disease

    Recruiting

    3 1
    Investigated Drugs:
    • Duvakitug
    Austria Belgium Bulgaria Czechia France Germany +9

  • Safety and Efficacy of Two Doses of OCUL101 Compared with Aflibercept in Patients with Neovascular Age‑Related Macular Degeneration

    Not yet recruiting

    4 1 1 1
    Investigated Drugs:
    • Aflibercept
    Czechia Hungary Latvia Poland

  • A study comparing the effectiveness of vorolanib and aflibercept in patients with diabetic macular edema

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • VOROLANIB
    • Aflibercept
    Czechia Germany Hungary
Previous Page
1 2 3 4 5
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!